期刊文献+

CPT-11联合化疗方案治疗晚期胃肠道癌的护理

CPT-11联合化疗方案治疗晚期胃肠道癌的护理
下载PDF
导出
摘要 目的探讨CPT-11联合化疗方案治疗晚期胃肠道癌的护理方法。方法对27例晚期胃肠道癌患者应用CPT-11联合方案化疗,化疗期间重点做好CPT-11毒性反应的护理,预防和减轻其毒性反应的发生。结果本组化疗毒性反应较低,均能顺利完成化疗,无1例因CPT-11毒性反应影响化疗。结论精心护理可预防和减轻CPT-11毒性反应的发生,确保化疗计划的顺利进行,提高治疗效果。
作者 程乐梅
出处 《临床护理杂志》 2007年第2期75-76,共2页 Journal of Clinical Nursing
关键词 喜树碱/类似物和衍生物 抗肿瘤联合化疗方案 胃肠肿瘤/护理 camptothecin/analogs& derivatives antineoplastic combined chemotherapy protocols gastrointestinal neoplasms/nursing
  • 相关文献

参考文献4

二级参考文献13

  • 1Van Cutsem E, Rougier PH, Droz JP, et al. Clinical benefit of irinotecan(CPT 11 ) in metastatic colorectal cancer (CRC)resistant to 5 Fu [J ]. Proc Am Soc Oncol, 1997, 16 ( 5 ): 268-271.
  • 2Bouzid K, Khalfallah S, Tujakowski J, et al. A randomized phase Ⅱ trial of irinotecan in combination with infusional or two different bolus 5-fluorouracil and folinic acid regimens as first-line therapy for advanced colorectal cancer[J]. J Ann Oncol, 2003 ,14(7):1106-1114.
  • 3Van Cutsem E, Cunningham D, Ten Bokkel Huinink WW, et al. Clinical activity and benefit of irinotecan (CPT-11 ) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-Fu)[J]. Eur J Cancer, 1999,35(1 ) :54-59.
  • 4Recchia F, Nuzzo A, Lalli A, et al. Multicenter phase Ⅱ study of CPT-11 fractionated over two days with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer[J]. Anticancer Res, 2003 ,23(3C):2903-2908.
  • 5Cassinello J, Lopez-Alvarez P, Martinez-Guisado A, et al.Phase Ⅱ study of weekly irinotecan (CPT-11 ) as second-line treatment of patients with advanced colorectal cancer[J]. Med Oncol, 2003,20 ( 1 ): 37-43.
  • 6Kazuhiko Arimori,Noriaki Kuroki,Muneaki Hidaka,Tomomi Iwakiri,Keishi Yamasaki,Manabu Okumura,Hiroshige Ono,Norito Takamura,Masahiko Kikuchi,Masahiro Nakano. Effect of P-Glycoprotein Modulator, Cyclosporin A, on the Gastrointestinal Excretion of Irinotecan and Its Metabolite SN-38 in Rats[J] 2003,Pharmaceutical Research(6):910~917
  • 7Kiyoshi Mori,Tetsuro Kondo,Yukari Kamiyama,Yasuhiko Kano,Keigo Tominaga. Preventive effect of Kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer[J] 2003,Cancer Chemotherapy and Pharmacology(5):403~406
  • 8Masato Horikawa,Yukio Kato,Yuichi Sugiyama. Reduced Gastrointestinal Toxicity Following Inhibition of the Biliary Excretion of Irinotecan and Its Metabolites by Probenecid in Rats[J] 2002,Pharmaceutical Research(9):1345~1353
  • 9Barbara Pro,Richard Lozano,Jaffer A. Ajani. Therapeutic Response to Octreotide in Patients with Refractory CPT-11 Induced Diarrhea[J] 2001,Investigational New Drugs(4):341~343
  • 10Akinobu Kurita,Shoichi Kado,Norimasa Kaneda,Masaharu Onoue,Shusuke Hashimoto,Teruo Yokokura. Modified irinotecan hydrochloride (CPT-11) administration schedule improves induction of delayed-onset diarrhea in rats[J] 2000,Cancer Chemotherapy and Pharmacology(3):211~220

共引文献172

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部